Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Panel Backs Approval Of Takeda/Orexigen's Obesity Drug Contrave

Dec 08 2010

• By PharmAsia News

Related Content

Takeda Bulks Up In Obesity With Orexigen Deal

Sep 02 2010

FDA, Orexigen Discussing CV Risk Study For Weight-Loss Drug Contrave

Dec 03 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window